Search Results

ACM Biolabs, a biotechnology company using its next-generation polymer-based delivery platform to develop new nano formulations for use in multiple therapeutic fields, announced positive topline results from a Phase I trial of ACM-001, the Company’s first clinical-stage development program.

ACM Biolabs announces the appointment of David Lawrence as Non-Executive Director.

As the industry witnesses a surge in demand for innovative antibodies on prevalent research targets, Creative Biolabs is poised to meet and exceed these expectations with their comprehensive suite of services.

PRISM BioLab, Co. Ltd. announced that it has entered into a target-exclusive research and licensing agreement with ONO PHARMACEUTICAL CO., LTD.

NSG BioLabs announces a new partnership with Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, to support biotech startups by providing needed resources such as product and applications expertise and its networks to advance startup research and development.

New England Biolabs (NEB ®) and Inorevia announce a collaboration to develop automated workflows to maximize data quality by preparation of sequence-ready libraries from challenging samples using NEBNext® library preparation reagents on Inorevia’s Magelia® automation platform.

At the recent European League Against Rheumatism Congress in Vienna, Austria, Nanjing Leads Biolabs Co., Ltd. delivered an oral presentation on its highly innovative therapeutic candidate LBL-047.

Nanjing Leads Biolabs Co., Ltd. announced that LBL-024, an anti-PD-L1/4-1BB bispecific antibody independently developed by Leads Biolabs with global intellectual property rights has received approval to conduct the single-arm pivotal study for registration and market authorization from the Center for Drug Evaluation of the National Medical Products Administration.

BioLabs and Promega announced the expansion of their collaborative efforts to accelerate life science innovation worldwide through support for early-stage start-up companies.